India tightens grip on Chinese imports with anti dumping duty on six products
Advertisement
New Delhi: In a move aimed at protecting domestic industries from unfair pricing imports, the Government of India has imposed anti-dumping duties on six Chinese products so far this month, with significant implications for the pharmaceutical and chemical sectors.
Among the targeted products are Acetonitrile (used in pharma sector), Vitamin-A Palmitate, PEDA (used in herbicide), Insoluble Sulphur, Potassium Tertiary Butoxide and decor paper. These duties will remain in effect for five years, following recommendations from the Directorate General of Trade Remedies (DGTR), an arm of the Ministry of Commerce.
While on PEDA, the duty will range from USD 1,305.6 to USD 2,017.9 per tonne, a duty of up to USD 481 per tonne has been imposed on Acetonitrile imported from China, Russia and Taiwan, PTI reported.
Similarly, the government has imposed a duty of up to USD 20.87 per Kg duty on Vitamin -A Palmitate imported from China, European Union and Switzerland; and up to USD 358 per tonne on import of Insoluble Sulphur, which is used in tyre industry, and imported from China and Japan.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.